LVIS™ Evo™ and HydroCoil® Embolic System for Intracranial Aneurysm Treatment

Active, not recruitingOBSERVATIONAL
Enrollment

206

Participants

Timeline

Start Date

January 14, 2022

Primary Completion Date

March 1, 2025

Study Completion Date

December 1, 2026

Conditions
Intracranial Aneurysm
Interventions
DEVICE

LVIS EVO and HydroCoil Embolic System

Stent assisted Coiling

Trial Locations (19)

Unknown

Charleroi University Hospital, Charleroi

Brest University Hospital, Brest

Limoges University Hospital, Limoges

Lyon University Hospital, Lyon

Marseille University Hospital, Marseille

Fondation Rothschild, Paris

Rouen University Hospital, Rouen

Universitätsklinikum Augsburg, Augsburg

Universitätsklinikum Knappschaftskrankenhaus, Bochum

Alfried Krupp Krankenhaus, Essen

Universitätsklinikum Münster, Münster

Azienda Ospedaliera Cannizzaro, Catania

Policlinico Martino Messina, Messina

Ospedali riuniti San Giovanni di Dio e Ruggi d'Aragona, Salerno

Royal Infirmary of Edinburgh, Edinburgh

Walton Centre, Liverpool

Charing Cross Hospital, London

King's College Hospital, London

The Royal London Hospital, London

All Listed Sponsors
lead

Microvention-Terumo, Inc.

INDUSTRY